NO950936L - 5-vinyl- og 5-etinylchinolon- og naftyridonkarboksylsyrer - Google Patents
5-vinyl- og 5-etinylchinolon- og naftyridonkarboksylsyrerInfo
- Publication number
- NO950936L NO950936L NO950936A NO950936A NO950936L NO 950936 L NO950936 L NO 950936L NO 950936 A NO950936 A NO 950936A NO 950936 A NO950936 A NO 950936A NO 950936 L NO950936 L NO 950936L
- Authority
- NO
- Norway
- Prior art keywords
- halogen
- vinyl
- carboxylic acids
- alkyl
- atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/762—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/771—Organic compounds containing hetero rings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Animal Husbandry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4408212A DE4408212A1 (de) | 1994-03-11 | 1994-03-11 | 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO950936D0 NO950936D0 (no) | 1995-03-10 |
| NO950936L true NO950936L (no) | 1995-09-12 |
Family
ID=6512492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO950936A NO950936L (no) | 1994-03-11 | 1995-03-10 | 5-vinyl- og 5-etinylchinolon- og naftyridonkarboksylsyrer |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US5578604A (fr) |
| EP (1) | EP0671391A1 (fr) |
| JP (1) | JPH07285941A (fr) |
| KR (1) | KR950032177A (fr) |
| CN (1) | CN1111629A (fr) |
| AU (1) | AU689189B2 (fr) |
| BG (1) | BG62001B1 (fr) |
| CA (1) | CA2144231A1 (fr) |
| CO (1) | CO4340737A1 (fr) |
| CZ (1) | CZ63895A3 (fr) |
| DE (1) | DE4408212A1 (fr) |
| DZ (1) | DZ1862A1 (fr) |
| EE (1) | EE9500020A (fr) |
| FI (1) | FI951101L (fr) |
| HR (1) | HRP950077A2 (fr) |
| HU (1) | HUT72071A (fr) |
| IL (1) | IL112936A0 (fr) |
| LV (1) | LV11469B (fr) |
| MA (1) | MA23475A1 (fr) |
| NO (1) | NO950936L (fr) |
| NZ (1) | NZ270657A (fr) |
| PE (1) | PE33895A1 (fr) |
| PL (1) | PL307583A1 (fr) |
| RU (1) | RU95103433A (fr) |
| SK (1) | SK31695A3 (fr) |
| SV (1) | SV1995000012A (fr) |
| TN (1) | TNSN95017A1 (fr) |
| YU (1) | YU15895A (fr) |
| ZA (1) | ZA952008B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4230804A1 (de) * | 1992-09-15 | 1994-03-17 | Bayer Ag | 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate |
| DE4427530A1 (de) * | 1994-08-04 | 1996-02-08 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
| US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
| DE19652219A1 (de) * | 1996-12-16 | 1998-06-18 | Bayer Ag | Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen |
| US6984499B2 (en) * | 1997-10-02 | 2006-01-10 | Idexx Laboratories, Inc. | Method and apparatus for concurrently detecting pathogenic organisms and antimicrobial susceptibility |
| JP2003516988A (ja) * | 1999-12-14 | 2003-05-20 | ニューロサーチ、アクティーゼルスカブ | 新規ヘテロアリール−ジアザビシクロアルカン類 |
| US7175988B2 (en) | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
| EP1397365B1 (fr) * | 2001-06-01 | 2005-02-16 | NeuroSearch A/S | Heteroaryl-diazabicyclo-alcanes a titre de modulateurs du snc |
| EP1399479B1 (fr) * | 2001-06-06 | 2009-09-16 | Neurosearch A/S | Recepteurs gaba a conduisant les cations et utilisation |
| US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
| SI1666477T1 (sl) | 2003-09-10 | 2013-10-30 | Kyorin Pharmaceutical Co., Ltd. | Derivati 7-(4-substituiran 3-ciklopropilaminometil-1-pirolidinil) kinolonkarboksilne kisline |
| CA2559809A1 (fr) | 2004-03-12 | 2005-11-10 | Human Genome Sciences, Inc. | Anticorps diriges contre le polypeptide humain hdgnr10, un recepteur de chimiokine (ccr5) couple a des proteines-g |
| US8222407B2 (en) | 2007-05-24 | 2012-07-17 | Kyorin Pharmaceutical Co., Ltd. | Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
| CN103724262B (zh) * | 2013-12-10 | 2016-05-18 | 广东省第二人民医院 | 一种氟喹诺酮银化合物及其制备方法和用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5591744A (en) * | 1987-04-16 | 1997-01-07 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
| EP0319906A3 (fr) * | 1987-12-11 | 1990-05-02 | Dainippon Pharmaceutical Co., Ltd. | Dérivés de la quinoléine, procédé de leur préparation et agent antibactérien les contenant |
| US4920120A (en) * | 1988-01-25 | 1990-04-24 | Warner-Lambert Company | Antibacterial agents |
| AU5123690A (en) * | 1989-03-13 | 1990-09-13 | Bristol-Myers Squibb Company | 5-substituted-1,4-dihydro-4-oxo-nephthyridine-3-carboxylate antibacterial agents |
| US5140033A (en) * | 1989-04-03 | 1992-08-18 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
| US5252734A (en) * | 1989-04-03 | 1993-10-12 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
| DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
| EP0593766B1 (fr) * | 1991-05-28 | 2000-09-06 | Daiichi Pharmaceutical Co., Ltd. | Derive d'acide pyridonecarboxylique |
-
1994
- 1994-03-11 DE DE4408212A patent/DE4408212A1/de not_active Withdrawn
-
1995
- 1995-02-20 HR HRP4408212.6A patent/HRP950077A2/hr not_active Application Discontinuation
- 1995-02-27 EP EP95102762A patent/EP0671391A1/fr not_active Withdrawn
- 1995-03-03 US US08/398,328 patent/US5578604A/en not_active Expired - Fee Related
- 1995-03-06 PE PE1995263451A patent/PE33895A1/es not_active Application Discontinuation
- 1995-03-06 CO CO95008716A patent/CO4340737A1/es unknown
- 1995-03-06 DZ DZ950026A patent/DZ1862A1/fr active
- 1995-03-06 AU AU13649/95A patent/AU689189B2/en not_active Ceased
- 1995-03-08 EE EE9500020A patent/EE9500020A/xx unknown
- 1995-03-08 YU YU15895A patent/YU15895A/sh unknown
- 1995-03-08 IL IL11293695A patent/IL112936A0/xx unknown
- 1995-03-08 CA CA002144231A patent/CA2144231A1/fr not_active Abandoned
- 1995-03-08 NZ NZ270657A patent/NZ270657A/en unknown
- 1995-03-08 PL PL95307583A patent/PL307583A1/xx unknown
- 1995-03-09 FI FI951101A patent/FI951101L/fi unknown
- 1995-03-09 BG BG99490A patent/BG62001B1/bg unknown
- 1995-03-09 JP JP7077134A patent/JPH07285941A/ja active Pending
- 1995-03-09 TN TNTNSN95017A patent/TNSN95017A1/fr unknown
- 1995-03-10 NO NO950936A patent/NO950936L/no unknown
- 1995-03-10 SV SV1995000012A patent/SV1995000012A/es unknown
- 1995-03-10 CZ CZ95638A patent/CZ63895A3/cs unknown
- 1995-03-10 HU HU9500728A patent/HUT72071A/hu unknown
- 1995-03-10 LV LVP-95-48A patent/LV11469B/lv unknown
- 1995-03-10 SK SK316-95A patent/SK31695A3/sk unknown
- 1995-03-10 MA MA23803A patent/MA23475A1/fr unknown
- 1995-03-10 KR KR1019950004888A patent/KR950032177A/ko not_active Withdrawn
- 1995-03-10 ZA ZA952008A patent/ZA952008B/xx unknown
- 1995-03-10 CN CN95102213A patent/CN1111629A/zh active Pending
- 1995-03-10 RU RU95103433/04A patent/RU95103433A/ru unknown
-
1996
- 1996-05-03 US US08/642,662 patent/US5659038A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO950936L (no) | 5-vinyl- og 5-etinylchinolon- og naftyridonkarboksylsyrer | |
| YU47099B (sh) | Postupak za dobijanje makrolidnih jedinjenja | |
| NZ240676A (en) | Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof | |
| MY107740A (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof | |
| EP0320118A3 (en) | Peptides with collagenase inhibiting activity | |
| BG104112A (en) | 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them | |
| FI882081A0 (fi) | 2-substituerade e-fusionerade (1,2,4) triazolo(1,5-c) pyrimidiner, farmaceutiska kompositioner och deras anvaendning. | |
| IL163625A0 (en) | Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same | |
| MXPA02001473A (es) | Azaindoles que tienen afinidad con el receptor de serotonina. | |
| NO960441L (no) | Benzopyraner og farmasöytiske forbindelser inneholdende dem | |
| IL106993A (en) | Benzenalkanoic acid derivatives and pharmaceutical compositions containing them | |
| WO2000051589A3 (fr) | Composes inhibiteurs d'atpase-(h+) de type vacuolaire, compositions et uitlisations associees | |
| IT1283635B1 (it) | Composti a scheletro camptotecinico isolati da mappia foetida e loro uso come sintoni per farmaci o come principi attivi | |
| ES8105748A1 (es) | Procedimiento para preparar derivados de pirimidina | |
| NO20052598L (no) | Nye 2,3-dihydro-4(1H)-pyridonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem. | |
| NO180443C (no) | Oktahydronaftalenoksimderivater samt farmasöytiske preparater som omfatter et slikt derivat til inhibering av kolesterolbiosyntese | |
| WO2000027378A3 (fr) | Derives de cystine en tant qu'agents therapeutiques pour des maladies liees aux metalloproteases matricielles | |
| CA2293433A1 (fr) | Derives de benzo(5,6)cyclohepta(1,2-b)pyridine s'utilisant comme inhibiteurs de transferase de proteine de farnesyl | |
| NO964672D0 (no) | Nye tetracykliske 1,4-oksazinforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger innholdende dem | |
| DK1118617T3 (da) | Forbindelser med en antioxiderende aktivitet, sammensætninger, som er anvendelige som levnedsmiddelintegratorer, som indeholder dem, samt fremgangsmåde til deres fremstilling | |
| JPS5782391A (en) | Thiopyrano(4,5-b)pyridin-2-one derivative | |
| JPS5590506A (en) | Photopolymerizable composition | |
| IE902272L (en) | Compositions of 5-phenyl-2-furan ketones | |
| NO303494B1 (no) | Tetrahydronaftalenderivater, fremgangsmÕte for deres fremstilling og farmas°ytisk preparat inneholdende et slikt derivat, samt mellomprodukter | |
| IL102702A (en) | OPTICALLY ACTIVE g-HALO- 2-AMINOALKANECARBOXYLIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THEIR USE FOR THE PREPARATION OF OPTICALLY ACTIVE PHOSPHORUS-CONTAINING a-AMINO ACIDS |